OncoImmune reported positive results from a late-stage study of a coronavirus therapeutic candidate. "Merck to Buy OncoImmune Amid Covid-19 Vaccine Development," at 6:59 a.m. ET incorrectly said that OncoImmune reported positive results from a late-stage study of a coronavirus vaccine candidate.
(END) Dow Jones Newswires
11-23-20 0822ET